FierceBiotech ٢٥ نوفمبر ٢٠٢٥ <a href="https://www.fiercebiotech.com/biotech/jjs-5b-alzheimers-hope-fades-anti-tau-antibody-posdinemab-flops-phase-2" hreflang="en">J&J's $5B Alzheimer's hope fades as anti-tau antibody posdinemab flops in phase 2</a> #Alzheimer hope #anti-tau antibody
FierceBiotech ٢٥ نوفمبر ٢٠٢٥ <a href="https://www.fiercebiotech.com/pharma/novos-shares-tumble-8-after-2-trial-misses-semaglutide-alzheimers-disease" hreflang="en">Novo shares tumble after 2 trial misses for semaglutide in Alzheimer's disease</a> #Alzheimer disease #Novo Nordisk
Endpoints News ٢٤ نوفمبر ٢٠٢٥ J&J’s tau-targeting antibody fails Phase 2 Alzheimer's study #fails Phase #Alzheimer study
Endpoints News ٢٤ نوفمبر ٢٠٢٥ Novo Nordisk's semaglutide misses in closely-watched Alzheimer’s trials #Novo Nordisk #closely-watched Alzheimer
BioWorld ٢٤ نوفمبر ٢٠٢٥ Novo’s semaglutide fails in phase III Alzheimer’s trials #phase III #III Alzheimer
BioPharma Dive ٢٤ نوفمبر ٢٠٢٥ Novo Nordisk’s GLP-1 misses goal in closely watched Alzheimer’s studies #Novo Nordisk #watched Alzheimer
BioWorld ٢٤ نوفمبر ٢٠٢٥ Novo’s semaglutide fails in phase III Alzheimer’s trials #III Alzheimer #phase III
BioPharma Dive ٢٤ نوفمبر ٢٠٢٥ APOE4 and CRISPR are reframing Alzheimer’s Risk #reframing Alzheimer #CRISPR brings
PharmaVoice ١٧ نوفمبر ٢٠٢٥ The next leap in Alzheimer’s R&D is coming, but not around the corner #couple drugs #true paradigm
Roche Media ١٤ أكتوبر ٢٠٢٥ Roche nabs FDA clearance for Alzheimer's biomarker blood test - Fierce Biotech #Fierce Biotech #nabs FDA
Roche Media ١٤ أكتوبر ٢٠٢٥ FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology - NeurologyLive #Clears Roche #FDA Clears
Roche Media ١٣ أكتوبر ٢٠٢٥ Roche, Lilly's blood test for Alzheimer's diagnosis gets US approval - Reuters #Lilly blood #Alzheimer diagnosis